Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,380 | -95,446 | -65,774 | -31,122 | -4,123 |
| Depreciation Amortization | 3,798 | 15,504 | 11,624 | 7,689 | 3,858 |
| Accounts receivable | 25,511 | 6,581 | 32,566 | 26,272 | 32,731 |
| Other Working Capital | 18,594 | 27,787 | 26,077 | 16,279 | 27,516 |
| Other Operating Activity | -22,245 | 15,278 | -14,942 | -14,569 | -26,850 |
| Operating Cash Flow | $5,278 | $-30,296 | $-10,449 | $4,549 | $33,132 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -10,224 | 120,458 | 94,804 | 47,288 | 19,784 |
| PPE Investments | -646 | -4,964 | -4,613 | -2,897 | -1,359 |
| Investing Cash Flow | $-10,870 | $115,494 | $90,191 | $44,391 | $18,425 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,416 | 4,081 | 1,122 | 1,032 | 1,030 |
| Financing Cash Flow | $3,416 | $4,081 | $1,122 | $1,032 | $1,030 |
| Beginning Cash Position | 184,508 | 95,229 | 95,229 | 95,229 | 95,229 |
| End Cash Position | 182,332 | 184,508 | 176,093 | 145,201 | 147,816 |
| Net Cash Flow | $-2,176 | $89,279 | $80,864 | $49,972 | $52,587 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,278 | -30,296 | -10,449 | 4,549 | 33,132 |
| Capital Expenditure | -646 | -4,964 | -4,613 | -2,897 | -1,359 |
| Free Cash Flow | 4,632 | -35,260 | -15,062 | 1,652 | 31,773 |